mood disorder consisting of the same cognitive and physical problems as in depression, with less severe but longer-lasting.
• Selective serotonin reuptake inhibitors (SSRIs)
• Serotonin and norepinephrine reuptake inhibitors (SNRIs)
• Tricyclic antidepressants (TCAs).
Dysthymia Clinical Trial Market: Improving healthcare infrastructure and rising number of dysthymia cases driving the growth of dysthymia clinical trial market.